রেক্টাল ক্যান্সার

A dose titration study and a combined superiority registry-based open-label randomized control trial is planned to answer the trial objectives. The study will be registry-based to allow simpler and more comprehensive follow-up. Patients with colorectal cancer will be treated with cytoreductive surgery (CRS) together with either standard oxaliplatin HIPEC (the control for the efficacy study) or oxaliplatin/irinotecan HIPEC in combination with 5-FU 24-hour EPIC. The 5-FU will be administered postoperatively when the abdomen is completely sutured. The drug is divided equally into 2 injections of …

Sponsor: Uppsala University
ClinicalTrials.gov-এ NCT04861558
রেজিস্ট্রিতে শেষ আপডেট ৩০ May 2025 · আমাদের পড়া ২০ Oct 2026